Boryeong Meloxicam Capsule (Meloxicam)

Adult dose

1. Acute exacerbation of osteoarthritis (degenerative arthritis): ○ Adults: Administer 7.5 mg of meloxicam orally once daily. If symptoms do not improve, the dose may be increased to 15 mg daily as needed. 2. Rheumatoid arthritis, ankylosing spondylitis: ○ Adults: Administer 15 mg of this medicine orally once daily. The dose may be reduced to 7.5 mg daily according to the response to treatment. This medicine should not be administered at doses exceeding 15 mg daily. It should be taken with water or another beverage during a meal. ○ In elderly patients or patients at increased risk of adverse reactions, treatment is usually initiated at a dose of 7.5 mg daily. ○ Patients with severe renal impairment receiving hemodialysis should not receive more than 7.5 mg daily.

This medication may pose a risk of gastrointestinal bleeding if taken by individuals who regularly consume more than three glasses of alcohol daily, and it is essential to consult a doctor or pharmacist. This medication can increase the risk of cardiovascular diseases, so special caution is needed for those with a history of heart disease or stroke or other risk factors. If symptoms such as chest pain, shortness of breath, weakness, or slurred speech occur, discontinue use immediately and consult a healthcare provider. This medication can cause serious gastrointestinal side effects such as gastrointestinal bleeding, ulcers, and perforation, so individuals with a history of gastrointestinal diseases, older adults, or those taking anticoagulants should exercise caution. Serious allergic reactions, rashes, blisters, or mucosal damage may occur, so if these symptoms arise, discontinue use immediately. This medication can affect kidney function, so individuals with kidney disease or those taking diuretics or blood pressure medications should periodically check kidney function. Women who are pregnant or planning to become pregnant should not take this medication, and it should also not be used during breastfeeding. This medication may affect blood coagulation, so patients taking anticoagulants should carefully monitor for the risk of bleeding. Dizziness, drowsiness, or blurred vision may occur during use, so caution should be exercised when driving or operating machinery. Regular blood tests and liver and kidney function tests should be conducted during long-term use to check for any abnormalities. Taking this medication in combination with other non-steroidal anti-inflammatory drugs, aspirin, anticoagulants, etc., may increase the risk of side effects, so whether to combine them should be discussed with a healthcare provider. Overdose of this medication can lead to serious symptoms such as nausea, vomiting, gastrointestinal bleeding, renal failure, and hepatic failure, so it is essential to adhere to the recommended dosage and immediately visit a medical facility in the case of an overdose. Keep this medication out of the reach of children, and store in its original container, sealed.

• Gastrointestinal bleeding
• cardiovascular thrombotic reactions
• myocardial infarction
• stroke
• gastrointestinal or intestinal bleeding
• ulcers
• perforation
• exfoliative dermatitis
• mucous membrane syndrome
• toxic epidermal necrolysis

This medication is sensitive to light, so it should be stored in a container that blocks light. Additionally, it is best to store it at a temperature between 1 degree and 30 degrees Celsius at room temperature. This way, the effectiveness of the medication can be well maintained.

Appearance

A hard capsule filled with a light yellow content, with a green upper and lower part.

Package unit

30 capsules/bottle, 300 capsules/bottle